# Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

> **NCT00859495** · PHASE2 · TERMINATED · sponsor: **Columbia University** · enrollment: 9 (actual)

## Conditions studied

- Pleural Mesothelioma

## Interventions

- **DRUG:** Doxorubicin
- **DRUG:** Cisplatin
- **DRUG:** Pemetrexed
- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT00859495
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859495, "Trimodal Lung-Sparing Treatment of Pleural Mesothelioma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00859495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*